- Filed
- Nov 14, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2017 · Nov 9, 2017 | 590.14M sh |
| Stockholders Equity | Q3 2017 · Sep 30, 2017 | −$26.83M |
| Stockholders Equity | Q3 2017 · Dec 31, 2016 | −$16.39M |
| Current Liabilities | Q3 2017 · Sep 30, 2017 | $57.24M |
| Current Liabilities | Q3 2017 · Dec 31, 2016 | $57.8M |
| Total Liabilities | Q3 2017 · Sep 30, 2017 | $60.64M |
| Total Liabilities | Q3 2017 · Dec 31, 2016 | $70.61M |
| Current Assets | Q3 2017 · Sep 30, 2017 | $16.13M |
| Current Assets | Q3 2017 · Dec 31, 2016 | $18.39M |
| Total Assets | Q3 2017 · Sep 30, 2017 | $33.99M |
| Total Assets | Q3 2017 · Dec 31, 2016 | $54.57M |
| Gross Profit | Q3 2017 · Sep 30, 2017 | $2.76M |
| Gross Profit | Q3 2017 · Sep 30, 2017 | $7.75M |
| Gross Profit | Q3 2017 · Sep 30, 2016 | $5.61M |
| Gross Profit | Q3 2017 · Sep 30, 2016 | $15.25M |
| Shares Diluted restated | Q3 2017 · Sep 30, 2016 | 25.43M sh |
| Shares Diluted | Q3 2017 · Sep 30, 2016 | 8.19M sh |
| Capex | Q3 2017 · Sep 30, 2016 | $124K |
| Operating Cash Flow | Q3 2017 · Sep 30, 2016 | −$12.5M |
| Cash And Equivalents | Q3 2017 · Sep 30, 2016 | $2.62M |
| Cash And Equivalents | Q3 2017 · Jan 1, 2016 | $7.94M |
| Eps Diluted restated | Q3 2017 · Sep 30, 2016 | $0.01 |
| Eps Diluted | Q3 2017 · Sep 30, 2016 | −$1.85 |
| Eps Basic restated | Q3 2017 · Sep 30, 2016 | $0.22 |
| Eps Basic | Q3 2017 · Sep 30, 2016 | −$1.85 |
| Sga Expense | Q3 2017 · Sep 30, 2016 | $3.76M |
| Sga Expense | Q3 2017 · Sep 30, 2016 | $11.83M |
| Operating Income | Q3 2017 · Sep 30, 2016 | −$3.8M |
| Operating Income | Q3 2017 · Sep 30, 2016 | −$11.66M |
| Cost Of Revenue | Q3 2017 · Sep 30, 2016 | $13.94M |
| Cost Of Revenue | Q3 2017 · Sep 30, 2016 | $44.53M |
| Revenue | Q3 2017 · Sep 30, 2016 | $19.55M |
| Revenue | Q3 2017 · Sep 30, 2016 | $59.78M |